Cloud-clone
SKU:SEA512Hu
ELISA Kit for Fibrinogen Like Protein 2 (FGL2)
ELISA Kit for Fibrinogen Like Protein 2 (FGL2)
Couldn't load pickup availability
Enzyme-linked immunosorbent assay for Antigen Detection.
Product No.
SEA512Hu
Organism Species
Homo sapiens (Human).
Sample Type
serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Test Method
Double-antibody Sandwich
Assay Length
3h
Detection Range
15.6-1,000ng/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 5.9ng/mL.
UOM
48T 96T 96T*5 96T*10 96T*100
Specificity
This assay has high sensitivity and excellent specificity for detection of Fibrinogen Like Protein 2 (FGL2).
No significant cross-reactivity or interference between Fibrinogen Like Protein 2 (FGL2) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Fibrinogen Like Protein 2 (FGL2) and the recovery rates were calculated by comparing the measured value to the expected amount of Fibrinogen Like Protein 2 (FGL2) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 92-99 | 95 |
| EDTA plasma(n=5) | 89-104 | 101 |
| heparin plasma(n=5) | 91-101 | 94 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Fibrinogen Like Protein 2 (FGL2) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Fibrinogen Like Protein 2 (FGL2) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Fibrinogen Like Protein 2 (FGL2) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 99-105% | 78-99% | 80-101% | 90-98% |
| EDTA plasma(n=5) | 89-97% | 94-105% | 79-97% | 82-92% |
| heparin plasma(n=5) | 89-96% | 88-96% | 94-102% | 99-105% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
| Standard | 2 | Standard Diluent | 1×20mL |
| Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
| Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
| TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
| Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.
| Magazine | Citations |
| Gut. | Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3 PubMed: 22637698 |
| Hepatogastroenterology. | Plasma fibrinogen-like protein 2 levels in patients with non-alcoholic fatty liver disease. PubMed: 22024080 |
| PLoS Pathogens | Programmed Death (PD)-1-Deficient Mice Are Extremely Sensitive to Murine Hepatitis Virus Strain-3 (MHV-3) Infection PubMed: PMC3131267 |
| Immunology letters | Tumor necrosis factor α (TNF-α) receptor-I is required for TNF-α-mediated fulminant virus hepatitis caused by murine hepatitis virus strain-3 infection. Pubmed: 24286726 |
| Immunol Lett. | Tumor necrosis factor α (TNF-α) receptor-I is required for TNF-α-mediated fulminant virus hepatitis caused by murine hepatitis virus strain-3 infection Pubmed:24286726 |
| NATURE COMMUNICATIONS | VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism pubmed:29109438 |
| Cancer Medicine | Soluble fibrinogen‐like protein 2 ameliorates acute rejection of liver transplantation in rat via inducing Kupffer cells M2 polarization Pubmed:29749104 |
| BMC Infectious Diseases | Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases Pubmed: 30419833 |
| Int J Gynaecol Obstet | Tandem mass tag©\based quantitative proteomic profiling of the serum of patients with abnormal uterine bleeding associated with copper intrauterine device 33354778 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPA512Hu01 | Recombinant Fibrinogen Like Protein 2 (FGL2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA512Hu01 | Polyclonal Antibody to Fibrinogen Like Protein 2 (FGL2) | WB; IHC; ICC; IP. |
| MAA512Hu22 | Monoclonal Antibody to Fibrinogen Like Protein 2 (FGL2) | WB; IHC; ICC; IP. |
| SEA512Hu | ELISA Kit for Fibrinogen Like Protein 2 (FGL2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA512Hu | Magnetic Luminex Assay Kit for Fibrinogen Like Protein 2 (FGL2) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
